CTKB · Company research
Cytek Biosciences, Inc. (CTKB): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
18records availableTechnology
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Cytek Biosciences, Inc. (CTKB) Stock Forecasts - Yahoo! Finance Canada | Cytek Biosciences, Inc. (CTKB) Stock Forecasts Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Oct 16, 2026 | neutral | 0 | 0.6 |
| Understanding Momentum Shifts in (CTKB) - Stock Traders Daily | Understanding Momentum Shifts in (CTKB) Stock Traders Daily | View source ↗ | Stock Traders Daily | Oct 9, 2026 | neutral | 0 | 0.6 |
| Fund Divests Cytek Biosciences (CTKB) Following Revenue Slowdown and Declining Profitability - Yahoo Finance | Fund Divests Cytek Biosciences (CTKB) Following Revenue Slowdown and Declining Profitability Yahoo Finance | View source ↗ | Yahoo Finance | Sep 29, 2026 | neutral | 0 | 0.6 |
| A new tool lets researchers analyze cell data online without rebuilding their work - Stock Titan | A new tool lets researchers analyze cell data online without rebuilding their work Stock Titan | View source ↗ | Stock Titan | Sep 23, 2026 | neutral | 0 | 0.6 |
| More than 4,200 peer-reviewed papers cite Cytek’s systems. It will showcase them at two fall meetings. - Stock Titan | More than 4,200 peer-reviewed papers cite Cytek’s systems. It will showcase them at two fall meetings. Stock Titan | View source ↗ | Stock Titan | Sep 3, 2026 | neutral | 0 | 0.6 |
| Cytek Biosciences (CTKB) CEO gets 120K shares, surrenders some for taxes - Stock Titan | Cytek Biosciences (CTKB) CEO gets 120K shares, surrenders some for taxes Stock Titan | View source ↗ | Stock Titan | Aug 20, 2026 | neutral | 0 | 0.6 |
| Cytek Biosciences (CTKB) Dips 2.3% to $4.18 as Support at $3.97 Comes into Focus - Stop Loss Guidance - dars.gov.et | Cytek Biosciences (CTKB) Dips 2.3% to $4.18 as Support at $3.97 Comes into Focus - Stop Loss Guidance dars.gov.et | View source ↗ | dars.gov.et | Aug 5, 2026 | neutral | 0 | 0.6 |
| Cytek Biosciences (CTKB) Dips 2.3% to $4.18 as Support at $3.97 Comes into Focus - Continuation Pattern Picks - dars.gov.et | Cytek Biosciences (CTKB) Dips 2.3% to $4.18 as Support at $3.97 Comes into Focus - Continuation Pattern Picks dars.gov.et | View source ↗ | dars.gov.et | Aug 5, 2026 | neutral | 0 | 0.6 |
| CTKB Forecast — Price Target — Prediction for 2027 - TradingView | CTKB Forecast — Price Target — Prediction for 2027 TradingView | View source ↗ | TradingView | Jun 27, 2026 | neutral | 0 | 0.6 |
| Cytek Biosciences (CTKB) Stock Sees Fair Value Falls After Analysts Cut Targets - Yahoo Finance | Cytek Biosciences (CTKB) Stock Sees Fair Value Falls After Analysts Cut Targets Yahoo Finance | View source ↗ | Yahoo Finance | Jun 17, 2026 | neutral | 0 | 0.6 |
| Cytek Biosciences Reports First Quarter 2026 Financial Results - GlobeNewswire | Cytek Biosciences Reports First Quarter 2026 Financial Results GlobeNewswire | View source ↗ | GlobeNewswire | May 7, 2026 | neutral | 0 | 0.6 |
| Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Share Price Is Still Matching Investor Opinion Despite 27% Slump - Simply Wall Street | Cytek Biosciences, Inc.'s (NASDAQ:CTKB) Share Price Is Still Matching Investor Opinion Despite 27% Slump Simply Wall Street | View source ↗ | Simply Wall Street | Feb 13, 2026 | neutral | 0 | 0.6 |
| Cytek Biosciences, Inc. Common Stock (CTKB) Stock - Gotrade | Cytek Biosciences, Inc. Common Stock (CTKB) Stock Gotrade | View source ↗ | Gotrade | Jan 13, 2026 | neutral | 0 | 0.6 |
| Cytek Biosciences (CTKB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga France | Cytek Biosciences (CTKB) Stock Analysis Report | Ratings, Financials & Performance Benzinga France | View source ↗ | Benzinga France | Nov 30, 2025 | neutral | 0 | 0.6 |
| Cytek Biosciences (CTKB) Stock Forecast and Price Target 2026 - MarketBeat | Cytek Biosciences (CTKB) Stock Forecast and Price Target 2026 MarketBeat | View source ↗ | MarketBeat | May 11, 2024 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Mar 27, 2024 | neutral | 0 | 0.6 |
| Cytek Biosciences (CTKB) - Zacks Investment Research | Cytek Biosciences (CTKB) Zacks Investment Research | View source ↗ | Zacks Investment Research | Jul 26, 2021 | neutral | 0 | 0.6 |
| Cytek Biosciences (Nasdaq:CTKB) - Stock Analysis - Simply Wall Street | Cytek Biosciences (Nasdaq:CTKB) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Jul 23, 2021 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.